Publications by authors named "Vera T C Valckx"
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy.
Best Pract Res Clin Haematol
September 2024
Article Synopsis
- * Targeting inhibitory receptors like KIRs and NKG2A may enhance NK cell function, allowing for better anti-tumor responses, especially in solid tumors where current therapies struggle.
- * The review discusses various strategies for modifying these inhibitory pathways while balancing effective activation of NK cells with safety considerations for patients.